Effects of short‐term supplementation with DHA ‐enriched phosphatidylcholine and phosphatidylserine on lipid profiles in the brain and liver of n‐3 PUFA ‐deficient mice in early life after weaning
Journal of the Science of Food and Agriculture · 2024
DOI: 10.1002/jsfa.13625 ↗At a glance
Journal article in Journal of the Science of Food and Agriculture, 2024. Written by Wei-Ya Zuo and 7 co-authors. Institution: College of Food Science and Engineering, Ocean University of China, Qingdao, China. Major MEDLINE topics: Phosphatidylserines, Liver, Phosphatidylcholines, Dietary Supplements. Cited 10 times so far (Crossref); 37 references. Funded by: National Natural Science Foundation of China.
Topics: Beatmung und Weaning
Abstract (original language)
BACKGROUND Lack of n‐3 polyunsaturated fatty acids during the period of maternity drastically lowers the docosahexaenoic acid (DHA) level in the brain of offspring and studies have demonstrated that different molecular forms of DHA are beneficial to brain development. The aim of this study was to investigate the effect of short‐term supplementation with DHA‐enriched phosphatidylserine (PS) and phosphatidylcholine (PC) on DHA levels in the liver and brain of congenital n‐3‐deficient mice. RESULTS Dietary supplementation with DHA significantly changed the fatty acid composition of various phospholipid molecules in the cerebral cortex and liver while DHA‐enriched phospholipid was more effective than DHA triglyceride (TG) in increasing brain and liver DHA. Both DHA‐PS and DHA‐PC could effectively increase the DHA levels, but DHA in the PS form was superior to PC in the contribution of DHA content in the brain ether‐linked PC (ePC) and liver lyso‐phosphatidylcholine molecular species. DHA‐PC showed more significant effects on the increase of DHA in liver TG, PC, ePC, phosphatidylethanolamine (PE) and PE plasmalogen (pPE) molecular species and decreasing the arachidonic acid level in liver PC plasmalogen, ePC, PE and pPE molecular species compared with DHA‐PS. CONCLUSION The effect of dietary interventions with different molecular forms of DHA for brain and liver lipid profiles is different, which may provide theoretical guidance for dietary supplementation of DHA for people. © 2024 Society of Chemical Industry.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Food Science and Engineering, Ocean University of China, Qingdao, China.
- Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng, China.
- Laboratory of Marine Drugs & Biological Products, Pilot National Laboratory for Marine Science and Technology (Qingdao), Qingdao, China.
- Laboratory of Nutrition Biochemistry, Department of Applied Biochemistry and Food Science, Saga University, Saga, Japan.
ORCID profiles: Yu-Ming Wang, Tian-Tian Zhang
Funding
- National Natural Science Foundation of China
Cite
APA
Zuo, W. Y., Wen, M., Zhao, Y. C., Li, X. Y., Xue, C. H., Yanagita, T., Wang, Y. M., & Zhang, T. T. (2024). Effects of short‐term supplementation with DHA ‐enriched phosphatidylcholine and phosphatidylserine on lipid profiles in the brain and liver of n‐3 PUFA ‐deficient mice in early life after weaning. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.13625
Vancouver
Zuo WY, Wen M, Zhao YC, Li XY, Xue CH, Yanagita T, et al. Effects of short‐term supplementation with DHA ‐enriched phosphatidylcholine and phosphatidylserine on lipid profiles in the brain and liver of n‐3 PUFA ‐deficient mice in early life after weaning. Journal of the Science of Food and Agriculture. 2024. doi:10.1002/jsfa.13625
BibTeX
@article{Zuo2024,
author = {Zuo, Wei-Ya and Wen, Min and Zhao, Ying-Cai and Li, Xiao-Yue and Xue, Chang-Hu and Yanagita, Teruyoshi and Wang, Yu-Ming and Zhang, Tian-Tian},
title = {Effects of short‐term supplementation with DHA ‐enriched phosphatidylcholine and phosphatidylserine on lipid profiles in the brain and liver of n‐3 PUFA ‐deficient mice in early life after weaning},
journal = {Journal of the Science of Food and Agriculture},
year = {2024},
doi = {10.1002/jsfa.13625}
}
EUVIMED